- Country: USA
- Summary: Co-Infection And Cancer (R21 Clinical Trial Not Allowed)
- UST Ref No: 110536385
- Deadline: 07 Jan 2026
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: PAR-25-083
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The Purpose Of This Funding Opportunity Announcement (Foa) Is To Enhance Mechanistic And Epidemiologic Investigations Addressing The Roles Of Co-Infection And Cancer To Shed Light On Presently Unestablished Pathways In Carcinogenesis That May Inform Prevention And Treatment Strategies For Infection-Related Cancers. Co-Infection Is Defined As The Occurrence Of Infections By Two Or More Infectious (Pathogenic Or Non-Pathogenic) Agents Either Concurrently Or Sequentially And Includes Both Acute And Chronic Infections By Viruses, Bacteria, Parasites, And/Or Other Microorganisms. Preference Will Be Given To Investigations Of Co-Infections With Known Oncogenic Agents (Excluding Human Immunodeficiency Virus [Hiv]) And Of Co-Infections That Engender Novel Opportunities For Prevention And Treatment.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINCo-Infection And Cancer (R21 Clinical Trial Not Allowed) - USA Tender
The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Co-Infection And Cancer (R21 Clinical Trial Not Allowed). This tender is published on USARFP under UST Ref No: 110536385 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2026-01-07.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
